Smart Multifunctional Nanoparticles in Cancer Theranostics: Progress and Prospect

Dipanjan Karati1, Swarupananda Mukherjee2, Ayon Dutta3

  • 1Department of Pharmaceutical Technology, School of Pharmacy, Techno India University, Kolkata, 700091, West Bengal, India.

PubMed
Abstract

Insights

Smart nanomaterials offer advanced cancer theranostics, improving tumor detection and treatment by enhancing cell-specific targeting. These nanoparticles overcome conventional therapy limitations, paving the way for precision medicine in oncology.

Area of Science:

  • Nanotechnology and Materials Science
  • Oncology and Cancer Research
  • Biomedical Engineering

Background:

  • Cancer remains a leading global cause of mortality.
  • Conventional cancer treatments like chemotherapy exhibit toxicities impacting healthy cells.
  • Novel strategies for enhanced cell-specific targeting are crucial for improved cancer care.

Purpose of the Study:

  • To review the scientific literature on nanoparticles in cancer theranostics.
  • To provide insights into the preventive and therapeutic potential of nanoparticles.
  • To explore smart multifunctional nanoparticles for cancer applications.

Main Methods:

  • Comprehensive literature search of Scopus, PubMed, Science Direct, and Google Scholar (2015-2023).
  • Keywords used: nanotechnology, cancer theranostics, polymer, smart multifunctional nanoparticles.
  • Synthesis of existing research on nanoparticle applications in oncology.

Main Results:

  • Nanomaterials serve as effective chemical biology tools for cancer theranostics.
  • Nanoparticles offer enhanced stability, biocompatibility, and cell permeability for precision targeting.
  • Smart nanomaterials, enabled by nanotechnology, revolutionize cancer diagnosis and treatment, with bio-based options showing promise.

Conclusions:

  • Nanoparticles (NPs) offer diverse cancer theranostic methodologies.
  • Smart nanomaterials significantly advance tumor detection and treatment strategies.
  • Addressing challenges in adoption can unlock the full potential of NPs in clinical oncology.